- Home
- EWCZ vs RNAC Comparison
EWCZ vs RNAC Comparison
Compare EWCZ & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWCZ | RNAC |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.2M | 217.1M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | EWCZ | RNAC |
|---|---|---|
| Price | $5.79 | $8.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $5.32 | ★ $38.80 |
| AVG Volume (30 Days) | ★ 1.3M | 125.3K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | $4.31 | N/A |
| Revenue Next Year | $2.09 | N/A |
| P/E Ratio | $21.96 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.73 | $5.98 |
| 52 Week High | $6.52 | $18.80 |
Technical Indicators
Market Signals| Indicator | EWCZ | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 78.53 | 58.95 |
| Support Level | $5.03 | $6.41 |
| Resistance Level | $5.84 | $10.49 |
| Average True Range (ATR) | 0.03 | 0.81 |
| MACD | -0.05 | 0.13 |
| Stochastic Oscillator | 90.00 | 70.82 |
Price Performance
Historical ComparisonAbout EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.